[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-353001-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-353001-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","integrating-qsar-machine-learning-biochemical-assays-and-molecular-dynamics-for-the-discovery-of-jak2-inhibitors-in-cervical-cancer","Integrating QSAR-Machine Learning, Biochemical Assays, and Molecular Dynamics for the Discovery of JAK2 Inhibitors in Cervical Cancer","","Cervical cancer remains a major global health challenge, where dysregulated JAK2 signaling constitutes a key molecular driver. Selective small-molecule JAK2 inhibitors for HPV-positive cervical cancer are still limited. This work integrates biochemical assays, QSAR-machine learning, and molecular dynamics simulations to identify potent JAK2 inhibitors, focusing on naphthalene-based derivatives evaluated in HeLa cytotoxicity and kinase inhibition assays.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/integrating-qsar-machine-learning-biochemical-assays-and-molecular-dynamics-for-the-discovery-of-jak2-inhibitors-in-cervical-cancer/353001/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/integrating-qsar-machine-learning-biochemical-assays-and-molecular-dynamics-for-the-discovery-of-jak2-inhibitors-in-cervical-cancer/353001.png","ImageObject",300,407,{"name":42,"@type":43},"Stanley","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-05","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",11,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What problem does the study address for HPV-positive cervical cancer?","Question",{"text":63,"@type":64},"It targets the limitation of selective small-molecule JAK2 inhibitors by focusing on dysregulated JAK2 signaling as a key molecular driver in cervical cancer.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were candidate JAK2 inhibitors identified in this research?",{"text":68,"@type":64},"The workflow combined biochemical assays, QSAR-machine learning to prioritize newly designed derivatives, and molecular dynamics simulations to study binding within the JAK2 ATP pocket.",{"name":70,"@type":61,"acceptedAnswer":71},"Which models and compounds showed the strongest results?",{"text":72,"@type":64},"Among three ensemble boosting models, the Categorical Boosting model achieved the best predictive performance and identified five active candidates with strong prediction–experiment agreement, including compounds such as D4 and D13 meeting drug-likeness criteria.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},353001,1790269535,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":128,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},2336477405376,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","This article is licensed under CC-BY-NC-ND 4.0  \n[pubs.acs.org/jcim](pubs.acs.org/jcim)  Article   \nIntegrating QSAR-Machine Learning, Biochemical Assays, and Molecular Dynamics for the Discovery of JAK2 Inhibitors in Cervical Cancer  \nDuangjai Todsaporn, Kamonpan Sanachai, Nattanit Suddee, Chompunud Kanjanapanyakom, Phornphimon Maitarad, Rattana Worayuthakarn, Chanat Aonbangkhen, Nopporn Thasana, and Thanyada Rungrotmongkol *  \n Cite This: J. Chem. Inf. Model. 2026, 66, 6067−6085  \nRead Online  \n\n|  |  |  |  |  |  |\n| --- | --- | --- | --- | --- | --- |\n| ACCESS   | Metrics & More |  |  Article Recommendations |  | *sı Supporting Information |\n\nABSTRACT: Cervical cancer remains a major global health challenge, where dysregulated JAK2 signaling constitutes a key molecular driver. Nevertheless, selective small-molecule JAK2 inhibitors for HPV-positive cervical cancer are still limited. Here, we integrated biochemical assays, QSAR-machine learning, and molecular dynamics simulations to identify potent JAK2 inhibitors. A series of naphthalene-based derivatives, including hydroxynaphthalenamide and phosphorylated dihydronaphthylamide analogs, were evaluated for cytotoxicity in HeLa cells and JAK2 kinase inhibition. Several compounds exhibited selective cytotoxicity with minimal activity toward normal fibroblasts, among which 2q and 2s showed low-nanomolar JAK2 inhibition and strong apoptosis induction through suppression of the JAK2/STAT3/STAT5 pro-tumorigenic signaling pathway. To accelerate hit identification, a QSAR-machine learning (QSAR-ML) framework was employed to prioritize 13 newly designed derivatives. Among three ensemble boosting models, the Categorical Boosting (CB) model demonstrated the strongest predictive capability, achieving a high R2 of 0.955 for the training set and a low RMSE of 0.156 for the test set. This model successfully identified five active candidates with strong prediction−experiment agreement (MAPE = 2.6−14.4%), with D4 and D13 meeting drug-likeness criteria and displaying potent nanomolar JAK2 inhibition. Finally, 1-μs molecular dynamics simulations revealed that hydrophobic contacts and hydrogen bonding cooperatively stabilize these inhibitors within the JAK2 ATP-binding pocket. Collectively, these findings establish a QSARML-guided strategy for accelerating JAK2 inhibitor discovery and highlight naphthalene-based scaffolds as promising leads for targeted cervical cancer therapy.  \n1. INTRODUCTION  \nCancer remains one of the leading causes of mortality among women worldwide, with cervical and breast cancers representing major global health concerns. Cervical cancer poses a significant public health challenge, especially in resourcelimited countries. Persistent infection with high-risk HPV strains, primarily types 16 and 18, is the primary cause of cervical cancer.1 Although HPV vaccination programs and improved screening methods have substantially reduced incidence in many regions, cervical cancer continues to exert a heavy global burden, with approximately 600,000 new cases and 340,000 deaths reported each year.2 Conventional  \n© 2026 The Authors. Published by American Chemical Society  \ntreatments for cervical cancer, such as surgery, radiation, and chemotherapy, with cisplatin being the most widely used chemotherapy drug, remain effective.3 However, these therapies are frequently associated with severe side effects, and their efficacy declines in advanced disease or in cases  \nReceived: February 8, 2026  \nRevised: April 20, 2026  \nAccepted: April 20, 2026  \nPublished: May 5, 2026  \n[https://doi.org/10.1021/acs.jcim.6c00414](https://doi.org/10.1021/acs.jcim.6c00414)  \n6067 J. Chem. Inf. Model. 2026, 66, 6067−6085  \nFigure 1. Overview of the integrated experimental and computational workflow used to identify and validate naphthalene-based JAK2 inhibitors.  \nwhere cancer cells develop drug resistance.4 Moreover, the lack of selectivity of traditional treatments results in collateral damage to heal","cbCaihnLwYlYLyhb","https://ap.wps.com/l/cbCaihnLwYlYLyhb","pdf",6768173,"English","# Abstract\n# Introduction","[{\"question\":\"What problem does the study address for HPV-positive cervical cancer?\",\"answer\":\"It targets the limitation of selective small-molecule JAK2 inhibitors by focusing on dysregulated JAK2 signaling as a key molecular driver in cervical cancer.\"},{\"question\":\"How were candidate JAK2 inhibitors identified in this research?\",\"answer\":\"The workflow combined biochemical assays, QSAR-machine learning to prioritize newly designed derivatives, and molecular dynamics simulations to study binding within the JAK2 ATP pocket.\"},{\"question\":\"Which models and compounds showed the strongest results?\",\"answer\":\"Among three ensemble boosting models, the Categorical Boosting model achieved the best predictive performance and identified five active candidates with strong prediction–experiment agreement, including compounds such as D4 and D13 meeting drug-likeness criteria.\"}]","Integrating QSAR-Machine Learning, Biochemical Assays, and Molecular Dynamics for the Discovery of JAK2 Inhibitors in Cervical Cancer | PDF",1790102515,48,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3610e61791902512939bc22ad7770fb7.webp",983,1296,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4542aff2638370b796304fd7409e7b0c.webp",982,1295,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7f8da45c5e365b9162acbfe4889aa7a9.webp",981,1293,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/07475d1c7d3aff7b70f25d0586be5239.webp",980,1292]